DSIP vs Pegzilarginase-nbln

Overview

DSIP is primarily a sleep & recovery peptide, while Pegzilarginase-nbln is used for weight management & metabolic.

This page compares DSIP and Pegzilarginase-nbln across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. DSIP is categorised under Sleep & Recovery, while Pegzilarginase-nbln falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. DSIP: not FDA-approved; compounding permitted with a prescription as of April 2026. Pegzilarginase-nbln: FDA-approved.

Dosing. DSIP is typically dosed at 100-300 mcg (before bed). Typical dosing for Pegzilarginase-nbln is not catalogued.

Can you stack them?

Some protocols combine peptides, but stacking DSIP and Pegzilarginase-nbln has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between DSIP and Pegzilarginase-nbln?

DSIP is primarily a sleep & recovery peptide, while Pegzilarginase-nbln is used for weight management & metabolic. DSIP is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Pegzilarginase-nbln is FDA-approved for one or more indications.

What is DSIP used for?

Delta sleep-inducing peptide.

What is Pegzilarginase-nbln used for?

PEGylated recombinant arginase enzyme for Arginase 1 Deficiency. FDA approved February 23, 2026.

Can you take DSIP and Pegzilarginase-nbln together?

Some users combine peptides within a single protocol, but stacking DSIP and Pegzilarginase-nbln has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is DSIP or Pegzilarginase-nbln FDA-approved?

DSIP is not FDA-approved; compounding permitted with a prescription (as of April 2026). Pegzilarginase-nbln is FDA-approved for one or more indications.